Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro (Q67898258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

18 September 2019

title

Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

18 September 2019

Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

3 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

3 December 2022

author name string

P. Dupuy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1826122

3 December 2022

M. Bagot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1826122

3 December 2022

L. Michel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1826122

3 December 2022

B. Descourt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1826122

3 December 2022

L. Dubertret

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1826122

3 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:S0022202X91904402?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

https://api.elsevier.com/content/article/PII:S0022202X91904402?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Journal of Investigative Dermatology

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

18 September 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

18 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

408-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826122 AND SRC:MED&resulttype=core&format=json

Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Cyclosporine inhibits macrophage-mediated antigen presentation

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The role of Langerhans cells in antigen presentation

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Epidermal cell production of thymocyte activating factor (ETAF)

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Biosynthesis and metabolism of prostaglandin E 2 in human skin

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

A method for the rapid isolation of human epidermal Langerhans cells using immunomagnetic microspheres

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Low-dose cyclosporin A in severe psoriasis. A double-blind study

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Cyclosporine affects the function of antigen-presenting cells

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Effect of cyclosporine on the antigen-presenting function of human and murine accessory cells.

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Langerhans cell production of interleukin-1

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes.

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

Cyclosporin depolarizes human lymphocytes: earliest observed effect on cell metabolism

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772

The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12469772